Gabapentin Capsule
Product Images NDC 60760-674

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

Chemical structure diagram of gabapentin, showing its cyclohexane ring and attached functional groups including an amino (CH2NH2) and carboxyl (CH2CO2H) group.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

Line graph depicting the mean pain score over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The timeline is divided into a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

A line graph showing mean pain scores over 7 weeks comparing placebo and two doses of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, and the y-axis shows mean pain scores. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders in two studies for placebo (PBO) and Gabapentin (GBP) at different dosages (3600 mg in Study 1; 1800 mg and 2400 mg in Study 2). The graph includes significance markers indicating statistical differences (p < 0.01 and p < 0.001).*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

A scatter plot chart showing the percent difference versus daily dose (mg) for gabapentin studied in three studies labeled a, b, and c. The x-axis represents daily dose ranging from 600 mg to 1800 mg, and the y-axis represents difference percentage from 2% to 22%. Data points for each study are indicated with different colored markers in the plot area.*

FDA Label Image

60760-674-90 (Gabapentin 60760 674 90)

Label for Gabapentin Capsules USP 300 mg in a quantity of 90 capsules. The label includes the NDC 60760-674-90 and mentions manufacturing by Graviti Pharmaceuticals Pvt. Ltd., Telangana, India. It is packaged by St. Mary's Medical Park Pharmacy with a specified storage temperature range of 15°-30° C (59°-86°F). The label also features barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.